Global Pulmonary Surfactant Market Research Report 2023

Pulmonary surfactant is a mixture of lipids and proteins which is secreted into the alveolar space by epithelial type II cells. The main function of surfactant is to lower the surface tension at the air/liquid interface within the alveoli of the lung.

The global Pulmonary Surfactant market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Pulmonary Surfactant is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Pulmonary Surfactant is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Pulmonary Surfactant include Boehringer Ingelheim, AbbVie, Lyomark Pharma, Tekzima (Noargen), ONY Biotech, Abbott, Aviva Systems Biology, LSBio and Biomatik, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Pulmonary Surfactant, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pulmonary Surfactant.

The Pulmonary Surfactant market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Pulmonary Surfactant market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pulmonary Surfactant manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

1.1 Product Overview and Scope of Pulmonary Surfactant

1.2 Pulmonary Surfactant Segment by Type

1.2.1 Global Pulmonary Surfactant Market Value Comparison by Type (2023-2029)

1.2.2 Synthetic Pulmonary Surfactants

1.2.3 Animal Derived Surfactants

1.3 Pulmonary Surfactant Segment by Application

1.3.1 Global Pulmonary Surfactant Market Value by Application: (2023-2029)

1.3.2 Hospital

1.3.3 laboratory

1.3.4 Others

1.4 Global Pulmonary Surfactant Market Size Estimates and Forecasts

1.4.1 Global Pulmonary Surfactant Revenue 2018-2029

1.4.2 Global Pulmonary Surfactant Sales 2018-2029

1.4.3 Global Pulmonary Surfactant Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Pulmonary Surfactant Sales Market Share by Manufacturers (2018-2023)

2.2 Global Pulmonary Surfactant Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Pulmonary Surfactant Average Price by Manufacturers (2018-2023)

2.4 Global Pulmonary Surfactant Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Pulmonary Surfactant, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Pulmonary Surfactant, Product Type & Application

2.7 Pulmonary Surfactant Market Competitive Situation and Trends

2.7.1 Pulmonary Surfactant Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Pulmonary Surfactant Players Market Share by Revenue

2.7.3 Global Pulmonary Surfactant Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Pulmonary Surfactant Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Pulmonary Surfactant Global Pulmonary Surfactant Sales by Region: 2018-2029

3.2.1 Global Pulmonary Surfactant Sales by Region: 2018-2023

3.2.2 Global Pulmonary Surfactant Sales by Region: 2024-2029

3.3 Global Pulmonary Surfactant Global Pulmonary Surfactant Revenue by Region: 2018-2029

3.3.1 Global Pulmonary Surfactant Revenue by Region: 2018-2023

3.3.2 Global Pulmonary Surfactant Revenue by Region: 2024-2029

3.4 North America Pulmonary Surfactant Market Facts & Figures by Country

3.4.1 North America Pulmonary Surfactant Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Pulmonary Surfactant Sales by Country (2018-2029)

3.4.3 North America Pulmonary Surfactant Revenue by Country (2018-2029)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Pulmonary Surfactant Market Facts & Figures by Country

3.5.1 Europe Pulmonary Surfactant Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Pulmonary Surfactant Sales by Country (2018-2029)

3.5.3 Europe Pulmonary Surfactant Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Pulmonary Surfactant Market Facts & Figures by Country

3.6.1 Asia Pacific Pulmonary Surfactant Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Pulmonary Surfactant Sales by Country (2018-2029)

3.6.3 Asia Pacific Pulmonary Surfactant Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Pulmonary Surfactant Market Facts & Figures by Country

3.7.1 Latin America Pulmonary Surfactant Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Pulmonary Surfactant Sales by Country (2018-2029)

3.7.3 Latin America Pulmonary Surfactant Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Pulmonary Surfactant Market Facts & Figures by Country

3.8.1 Middle East and Africa Pulmonary Surfactant Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Pulmonary Surfactant Sales by Country (2018-2029)

3.8.3 Middle East and Africa Pulmonary Surfactant Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4.1 Global Pulmonary Surfactant Sales by Type (2018-2029)

4.1.1 Global Pulmonary Surfactant Sales by Type (2018-2023)

4.1.2 Global Pulmonary Surfactant Sales by Type (2024-2029)

4.1.3 Global Pulmonary Surfactant Sales Market Share by Type (2018-2029)

4.2 Global Pulmonary Surfactant Revenue by Type (2018-2029)

4.2.1 Global Pulmonary Surfactant Revenue by Type (2018-2023)

4.2.2 Global Pulmonary Surfactant Revenue by Type (2024-2029)

4.2.3 Global Pulmonary Surfactant Revenue Market Share by Type (2018-2029)

4.3 Global Pulmonary Surfactant Price by Type (2018-2029)

5.1 Global Pulmonary Surfactant Sales by Application (2018-2029)

5.1.1 Global Pulmonary Surfactant Sales by Application (2018-2023)

5.1.2 Global Pulmonary Surfactant Sales by Application (2024-2029)

5.1.3 Global Pulmonary Surfactant Sales Market Share by Application (2018-2029)

5.2 Global Pulmonary Surfactant Revenue by Application (2018-2029)

5.2.1 Global Pulmonary Surfactant Revenue by Application (2018-2023)

5.2.2 Global Pulmonary Surfactant Revenue by Application (2024-2029)

5.2.3 Global Pulmonary Surfactant Revenue Market Share by Application (2018-2029)

5.3 Global Pulmonary Surfactant Price by Application (2018-2029)

6.1 Boehringer Ingelheim

6.1.1 Boehringer Ingelheim Corporation Information

6.1.2 Boehringer Ingelheim Description and Business Overview

6.1.3 Boehringer Ingelheim Pulmonary Surfactant Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Boehringer Ingelheim Pulmonary Surfactant Product Portfolio

6.1.5 Boehringer Ingelheim Recent Developments/Updates

6.2 AbbVie

6.2.1 AbbVie Corporation Information

6.2.2 AbbVie Description and Business Overview

6.2.3 AbbVie Pulmonary Surfactant Sales, Revenue and Gross Margin (2018-2023)

6.2.4 AbbVie Pulmonary Surfactant Product Portfolio

6.2.5 AbbVie Recent Developments/Updates

6.3 Lyomark Pharma

6.3.1 Lyomark Pharma Corporation Information

6.3.2 Lyomark Pharma Description and Business Overview

6.3.3 Lyomark Pharma Pulmonary Surfactant Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Lyomark Pharma Pulmonary Surfactant Product Portfolio

6.3.5 Lyomark Pharma Recent Developments/Updates

6.4 Tekzima (Noargen)

6.4.1 Tekzima (Noargen) Corporation Information

6.4.2 Tekzima (Noargen) Description and Business Overview

6.4.3 Tekzima (Noargen) Pulmonary Surfactant Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Tekzima (Noargen) Pulmonary Surfactant Product Portfolio

6.4.5 Tekzima (Noargen) Recent Developments/Updates

6.5 ONY Biotech

6.5.1 ONY Biotech Corporation Information

6.5.2 ONY Biotech Description and Business Overview

6.5.3 ONY Biotech Pulmonary Surfactant Sales, Revenue and Gross Margin (2018-2023)

6.5.4 ONY Biotech Pulmonary Surfactant Product Portfolio

6.5.5 ONY Biotech Recent Developments/Updates

6.6 Abbott

6.6.1 Abbott Corporation Information

6.6.2 Abbott Description and Business Overview

6.6.3 Abbott Pulmonary Surfactant Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Abbott Pulmonary Surfactant Product Portfolio

6.6.5 Abbott Recent Developments/Updates

6.7 Aviva Systems Biology

6.6.1 Aviva Systems Biology Corporation Information

6.6.2 Aviva Systems Biology Description and Business Overview

6.6.3 Aviva Systems Biology Pulmonary Surfactant Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Aviva Systems Biology Pulmonary Surfactant Product Portfolio

6.7.5 Aviva Systems Biology Recent Developments/Updates

6.8 LSBio

6.8.1 LSBio Corporation Information

6.8.2 LSBio Description and Business Overview

6.8.3 LSBio Pulmonary Surfactant Sales, Revenue and Gross Margin (2018-2023)

6.8.4 LSBio Pulmonary Surfactant Product Portfolio

6.8.5 LSBio Recent Developments/Updates

6.9 Biomatik

6.9.1 Biomatik Corporation Information

6.9.2 Biomatik Description and Business Overview

6.9.3 Biomatik Pulmonary Surfactant Sales, Revenue and Gross Margin (2018-2023)

6.9.4 Biomatik Pulmonary Surfactant Product Portfolio

6.9.5 Biomatik Recent Developments/Updates

6.10 Biorbyt

6.10.1 Biorbyt Corporation Information

6.10.2 Biorbyt Description and Business Overview

6.10.3 Biorbyt Pulmonary Surfactant Sales, Revenue and Gross Margin (2018-2023)

6.10.4 Biorbyt Pulmonary Surfactant Product Portfolio

6.10.5 Biorbyt Recent Developments/Updates

6.11 Reddot Biotech

6.11.1 Reddot Biotech Corporation Information

6.11.2 Reddot Biotech Pulmonary Surfactant Description and Business Overview

6.11.3 Reddot Biotech Pulmonary Surfactant Sales, Revenue and Gross Margin (2018-2023)

6.11.4 Reddot Biotech Pulmonary Surfactant Product Portfolio

6.11.5 Reddot Biotech Recent Developments/Updates

6.12 XpressBio

6.12.1 XpressBio Corporation Information

6.12.2 XpressBio Pulmonary Surfactant Description and Business Overview

6.12.3 XpressBio Pulmonary Surfactant Sales, Revenue and Gross Margin (2018-2023)

6.12.4 XpressBio Pulmonary Surfactant Product Portfolio

6.12.5 XpressBio Recent Developments/Updates

6.13 Creative Diagnostics

6.13.1 Creative Diagnostics Corporation Information

6.13.2 Creative Diagnostics Pulmonary Surfactant Description and Business Overview

6.13.3 Creative Diagnostics Pulmonary Surfactant Sales, Revenue and Gross Margin (2018-2023)

6.13.4 Creative Diagnostics Pulmonary Surfactant Product Portfolio

6.13.5 Creative Diagnostics Recent Developments/Updates

6.14 Nanjing Norris Pharm Technology

6.14.1 Nanjing Norris Pharm Technology Corporation Information

6.14.2 Nanjing Norris Pharm Technology Pulmonary Surfactant Description and Business Overview

6.14.3 Nanjing Norris Pharm Technology Pulmonary Surfactant Sales, Revenue and Gross Margin (2018-2023)

6.14.4 Nanjing Norris Pharm Technology Pulmonary Surfactant Product Portfolio

6.14.5 Nanjing Norris Pharm Technology Recent Developments/Updates

6.15 Windtree Therapeutics

6.15.1 Windtree Therapeutics Corporation Information

6.15.2 Windtree Therapeutics Pulmonary Surfactant Description and Business Overview

6.15.3 Windtree Therapeutics Pulmonary Surfactant Sales, Revenue and Gross Margin (2018-2023)

6.15.4 Windtree Therapeutics Pulmonary Surfactant Product Portfolio

6.15.5 Windtree Therapeutics Recent Developments/Updates

7.1 Pulmonary Surfactant Industry Chain Analysis

7.2 Pulmonary Surfactant Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Pulmonary Surfactant Production Mode & Process

7.4 Pulmonary Surfactant Sales and Marketing

7.4.1 Pulmonary Surfactant Sales Channels

7.4.2 Pulmonary Surfactant Distributors

7.5 Pulmonary Surfactant Customers

8.1 Pulmonary Surfactant Industry Trends

8.2 Pulmonary Surfactant Market Drivers

8.3 Pulmonary Surfactant Market Challenges

8.4 Pulmonary Surfactant Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Pulmonary Surfactant Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Pulmonary Surfactant Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Pulmonary Surfactant Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Pulmonary Surfactant Sales (K Units) of Key Manufacturers (2018-2023)

    Table 5. Global Pulmonary Surfactant Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Pulmonary Surfactant Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Pulmonary Surfactant Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Pulmonary Surfactant Average Price (USD/Unit) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Pulmonary Surfactant, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Pulmonary Surfactant, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Pulmonary Surfactant, Product Type & Application

    Table 12. Global Key Manufacturers of Pulmonary Surfactant, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Pulmonary Surfactant by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pulmonary Surfactant as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Pulmonary Surfactant Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Pulmonary Surfactant Sales by Region (2018-2023) & (K Units)

    Table 18. Global Pulmonary Surfactant Sales Market Share by Region (2018-2023)

    Table 19. Global Pulmonary Surfactant Sales by Region (2024-2029) & (K Units)

    Table 20. Global Pulmonary Surfactant Sales Market Share by Region (2024-2029)

    Table 21. Global Pulmonary Surfactant Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Pulmonary Surfactant Revenue Market Share by Region (2018-2023)

    Table 23. Global Pulmonary Surfactant Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Pulmonary Surfactant Revenue Market Share by Region (2024-2029)

    Table 25. North America Pulmonary Surfactant Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Pulmonary Surfactant Sales by Country (2018-2023) & (K Units)

    Table 27. North America Pulmonary Surfactant Sales by Country (2024-2029) & (K Units)

    Table 28. North America Pulmonary Surfactant Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Pulmonary Surfactant Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Pulmonary Surfactant Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Pulmonary Surfactant Sales by Country (2018-2023) & (K Units)

    Table 32. Europe Pulmonary Surfactant Sales by Country (2024-2029) & (K Units)

    Table 33. Europe Pulmonary Surfactant Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Pulmonary Surfactant Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Pulmonary Surfactant Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Pulmonary Surfactant Sales by Region (2018-2023) & (K Units)

    Table 37. Asia Pacific Pulmonary Surfactant Sales by Region (2024-2029) & (K Units)

    Table 38. Asia Pacific Pulmonary Surfactant Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Pulmonary Surfactant Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Pulmonary Surfactant Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Pulmonary Surfactant Sales by Country (2018-2023) & (K Units)

    Table 42. Latin America Pulmonary Surfactant Sales by Country (2024-2029) & (K Units)

    Table 43. Latin America Pulmonary Surfactant Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Pulmonary Surfactant Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Pulmonary Surfactant Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Pulmonary Surfactant Sales by Country (2018-2023) & (K Units)

    Table 47. Middle East & Africa Pulmonary Surfactant Sales by Country (2024-2029) & (K Units)

    Table 48. Middle East & Africa Pulmonary Surfactant Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Pulmonary Surfactant Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Pulmonary Surfactant Sales (K Units) by Type (2018-2023)

    Table 51. Global Pulmonary Surfactant Sales (K Units) by Type (2024-2029)

    Table 52. Global Pulmonary Surfactant Sales Market Share by Type (2018-2023)

    Table 53. Global Pulmonary Surfactant Sales Market Share by Type (2024-2029)

    Table 54. Global Pulmonary Surfactant Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Pulmonary Surfactant Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Pulmonary Surfactant Revenue Market Share by Type (2018-2023)

    Table 57. Global Pulmonary Surfactant Revenue Market Share by Type (2024-2029)

    Table 58. Global Pulmonary Surfactant Price (USD/Unit) by Type (2018-2023)

    Table 59. Global Pulmonary Surfactant Price (USD/Unit) by Type (2024-2029)

    Table 60. Global Pulmonary Surfactant Sales (K Units) by Application (2018-2023)

    Table 61. Global Pulmonary Surfactant Sales (K Units) by Application (2024-2029)

    Table 62. Global Pulmonary Surfactant Sales Market Share by Application (2018-2023)

    Table 63. Global Pulmonary Surfactant Sales Market Share by Application (2024-2029)

    Table 64. Global Pulmonary Surfactant Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Pulmonary Surfactant Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Pulmonary Surfactant Revenue Market Share by Application (2018-2023)

    Table 67. Global Pulmonary Surfactant Revenue Market Share by Application (2024-2029)

    Table 68. Global Pulmonary Surfactant Price (USD/Unit) by Application (2018-2023)

    Table 69. Global Pulmonary Surfactant Price (USD/Unit) by Application (2024-2029)

    Table 70. Boehringer Ingelheim Corporation Information

    Table 71. Boehringer Ingelheim Description and Business Overview

    Table 72. Boehringer Ingelheim Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 73. Boehringer Ingelheim Pulmonary Surfactant Product

    Table 74. Boehringer Ingelheim Recent Developments/Updates

    Table 75. AbbVie Corporation Information

    Table 76. AbbVie Description and Business Overview

    Table 77. AbbVie Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 78. AbbVie Pulmonary Surfactant Product

    Table 79. AbbVie Recent Developments/Updates

    Table 80. Lyomark Pharma Corporation Information

    Table 81. Lyomark Pharma Description and Business Overview

    Table 82. Lyomark Pharma Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 83. Lyomark Pharma Pulmonary Surfactant Product

    Table 84. Lyomark Pharma Recent Developments/Updates

    Table 85. Tekzima (Noargen) Corporation Information

    Table 86. Tekzima (Noargen) Description and Business Overview

    Table 87. Tekzima (Noargen) Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 88. Tekzima (Noargen) Pulmonary Surfactant Product

    Table 89. Tekzima (Noargen) Recent Developments/Updates

    Table 90. ONY Biotech Corporation Information

    Table 91. ONY Biotech Description and Business Overview

    Table 92. ONY Biotech Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 93. ONY Biotech Pulmonary Surfactant Product

    Table 94. ONY Biotech Recent Developments/Updates

    Table 95. Abbott Corporation Information

    Table 96. Abbott Description and Business Overview

    Table 97. Abbott Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 98. Abbott Pulmonary Surfactant Product

    Table 99. Abbott Recent Developments/Updates

    Table 100. Aviva Systems Biology Corporation Information

    Table 101. Aviva Systems Biology Description and Business Overview

    Table 102. Aviva Systems Biology Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 103. Aviva Systems Biology Pulmonary Surfactant Product

    Table 104. Aviva Systems Biology Recent Developments/Updates

    Table 105. LSBio Corporation Information

    Table 106. LSBio Description and Business Overview

    Table 107. LSBio Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 108. LSBio Pulmonary Surfactant Product

    Table 109. LSBio Recent Developments/Updates

    Table 110. Biomatik Corporation Information

    Table 111. Biomatik Description and Business Overview

    Table 112. Biomatik Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 113. Biomatik Pulmonary Surfactant Product

    Table 114. Biomatik Recent Developments/Updates

    Table 115. Biorbyt Corporation Information

    Table 116. Biorbyt Description and Business Overview

    Table 117. Biorbyt Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 118. Biorbyt Pulmonary Surfactant Product

    Table 119. Biorbyt Recent Developments/Updates

    Table 120. Reddot Biotech Corporation Information

    Table 121. Reddot Biotech Description and Business Overview

    Table 122. Reddot Biotech Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 123. Reddot Biotech Pulmonary Surfactant Product

    Table 124. Reddot Biotech Recent Developments/Updates

    Table 125. XpressBio Corporation Information

    Table 126. XpressBio Description and Business Overview

    Table 127. XpressBio Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 128. XpressBio Pulmonary Surfactant Product

    Table 129. XpressBio Recent Developments/Updates

    Table 130. Creative Diagnostics Corporation Information

    Table 131. Creative Diagnostics Description and Business Overview

    Table 132. Creative Diagnostics Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 133. Creative Diagnostics Pulmonary Surfactant Product

    Table 134. Creative Diagnostics Recent Developments/Updates

    Table 135. Nanjing Norris Pharm Technology Corporation Information

    Table 136. Nanjing Norris Pharm Technology Description and Business Overview

    Table 137. Nanjing Norris Pharm Technology Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 138. Nanjing Norris Pharm Technology Pulmonary Surfactant Product

    Table 139. Nanjing Norris Pharm Technology Recent Developments/Updates

    Table 140. Windtree Therapeutics Corporation Information

    Table 141. Windtree Therapeutics Description and Business Overview

    Table 142. Windtree Therapeutics Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 143. Windtree Therapeutics Pulmonary Surfactant Product

    Table 144. Windtree Therapeutics Recent Developments/Updates

    Table 145. Key Raw Materials Lists

    Table 146. Raw Materials Key Suppliers Lists

    Table 147. Pulmonary Surfactant Distributors List

    Table 148. Pulmonary Surfactant Customers List

    Table 149. Pulmonary Surfactant Market Trends

    Table 150. Pulmonary Surfactant Market Drivers

    Table 151. Pulmonary Surfactant Market Challenges

    Table 152. Pulmonary Surfactant Market Restraints

    Table 153. Research Programs/Design for This Report

    Table 154. Key Data Information from Secondary Sources

    Table 155. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Pulmonary Surfactant

    Figure 2. Global Pulmonary Surfactant Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Pulmonary Surfactant Market Share by Type in 2022 & 2029

    Figure 4. Synthetic Pulmonary Surfactants Product Picture

    Figure 5. Animal Derived Surfactants Product Picture

    Figure 6. Global Pulmonary Surfactant Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Pulmonary Surfactant Market Share by Application in 2022 & 2029

    Figure 8. Hospital

    Figure 9. laboratory

    Figure 10. Others

    Figure 11. Global Pulmonary Surfactant Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 12. Global Pulmonary Surfactant Market Size (2018-2029) & (US$ Million)

    Figure 13. Global Pulmonary Surfactant Sales (2018-2029) & (K Units)

    Figure 14. Global Pulmonary Surfactant Average Price (USD/Unit) & (2018-2029)

    Figure 15. Pulmonary Surfactant Report Years Considered

    Figure 16. Pulmonary Surfactant Sales Share by Manufacturers in 2022

    Figure 17. Global Pulmonary Surfactant Revenue Share by Manufacturers in 2022

    Figure 18. The Global 5 and 10 Largest Pulmonary Surfactant Players: Market Share by Revenue in 2022

    Figure 19. Pulmonary Surfactant Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 20. Global Pulmonary Surfactant Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 21. North America Pulmonary Surfactant Sales Market Share by Country (2018-2029)

    Figure 22. North America Pulmonary Surfactant Revenue Market Share by Country (2018-2029)

    Figure 23. U.S. Pulmonary Surfactant Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 24. Canada Pulmonary Surfactant Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 25. Europe Pulmonary Surfactant Sales Market Share by Country (2018-2029)

    Figure 26. Europe Pulmonary Surfactant Revenue Market Share by Country (2018-2029)

    Figure 27. Germany Pulmonary Surfactant Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 28. France Pulmonary Surfactant Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 29. U.K. Pulmonary Surfactant Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. Italy Pulmonary Surfactant Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. Russia Pulmonary Surfactant Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. Asia Pacific Pulmonary Surfactant Sales Market Share by Region (2018-2029)

    Figure 33. Asia Pacific Pulmonary Surfactant Revenue Market Share by Region (2018-2029)

    Figure 34. China Pulmonary Surfactant Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 35. Japan Pulmonary Surfactant Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. South Korea Pulmonary Surfactant Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. India Pulmonary Surfactant Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. Australia Pulmonary Surfactant Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. Taiwan Pulmonary Surfactant Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. Indonesia Pulmonary Surfactant Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Thailand Pulmonary Surfactant Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Malaysia Pulmonary Surfactant Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Philippines Pulmonary Surfactant Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Latin America Pulmonary Surfactant Sales Market Share by Country (2018-2029)

    Figure 45. Latin America Pulmonary Surfactant Revenue Market Share by Country (2018-2029)

    Figure 46. Mexico Pulmonary Surfactant Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 47. Brazil Pulmonary Surfactant Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Argentina Pulmonary Surfactant Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 49. Middle East & Africa Pulmonary Surfactant Sales Market Share by Country (2018-2029)

    Figure 50. Middle East & Africa Pulmonary Surfactant Revenue Market Share by Country (2018-2029)

    Figure 51. Turkey Pulmonary Surfactant Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 52. Saudi Arabia Pulmonary Surfactant Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. U.A.E Pulmonary Surfactant Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 54. Global Sales Market Share of Pulmonary Surfactant by Type (2018-2029)

    Figure 55. Global Revenue Market Share of Pulmonary Surfactant by Type (2018-2029)

    Figure 56. Global Pulmonary Surfactant Price (USD/Unit) by Type (2018-2029)

    Figure 57. Global Sales Market Share of Pulmonary Surfactant by Application (2018-2029)

    Figure 58. Global Revenue Market Share of Pulmonary Surfactant by Application (2018-2029)

    Figure 59. Global Pulmonary Surfactant Price (USD/Unit) by Application (2018-2029)

    Figure 60. Pulmonary Surfactant Value Chain

    Figure 61. Pulmonary Surfactant Production Process

    Figure 62. Channels of Distribution (Direct Vs Distribution)

    Figure 63. Distributors Profiles

    Figure 64. Bottom-up and Top-down Approaches for This Report

    Figure 65. Data Triangulation

    Figure 66. Key Executives Interviewed